MedPath

Intranasal Dexmedetomidine and Remifentanil and hemodynamic changes after intubation in childre

Phase 3
Recruiting
Conditions
Hemodynamic and Respiratory complications after intubation.
Registration Number
IRCT20160301026866N7
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
105
Inclusion Criteria

all children ages 6 to 12 years of age with general anesthetics, ASAI and ASAII grades, and consent from the parents of the patient to participate in the study.

Exclusion Criteria

The criteria for not attending the study include children under 6 years of age and over 12 years of age, underlying illness (inherited and genetic diseases, metabolic diseases, etc.), and parents' disagreement for participation in the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hemodynamic change. Timepoint: One minute after the drug is given and one minute after the intubation. Method of measurement: Anesthetic monitoring device.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath